Tuesday, November 16, 2010

What's in a Name?

Today's post is the first in a two-part series about the importance of the terms we use. It was written by Dr. Jannine Cody, president of the Registry and director of the Chromosome 18 Clinical Research Center!

I once read an article in a medical journal in which the author made the comment that Trisomy 21 was the leading cause of Down syndrome. My first thought was, “Well, duh!” I wondered what else he thought could cause Down syndrome...Maybe bad karma? But I have come to appreciate that there are fundamentally different approaches to describing a condition. In the case of Down syndrome and trisomy 21, the two terms seem synonymous and are often used interchangeably. But, in our world, where each individual has a slightly different chromosome change, the terms “trisomy 21” and “Down syndrome” are significantly different. The term “trisomy 21” describes a genetic change, namely, an extra copy of chromosome 21. The term “Down syndrome” describes the collection of medical and developmental issues that are caused by the extra chromosome. We need to understand the difference and be sure we use the correct terms. If we don’t, then we inadvertently send the wrong message to the medical community.

A syndrome is a group of characteristics that often occur together and therefore are presumed to have the same underlying cause. So, syndromes are defined by the physical characteristics or medical findings (what I usually call the “phenotype”). In many cases, the cause is unknown – or, at least, the cause was unknown at the time that someone recognizes and names a group of characteristics that co-occur in more than one person. An example is Pitt Hopkins syndrome. This is a group of characteristics that includes a broad mouth with full lips, breathing abnormalities, and severe intellectual disability. People who fit this clinical description were said to have Pitt Hopkins syndrome. Now we know that the syndrome has 3 possible causes. In other words, abnormalities in one of three different genes can cause Pitt Hopkins syndrome. So now they are renamed Pitt Hopkins-like I, Pitt Hopkins-like II etc. This renaming aligns the genetic cause (genotype) with the clinical presentation (phenotype).

However, many chromosome abnormalities, like 18p-, 18q-, Ring 18, Tetrasomy 18p and Trisomy 18 are defined by the genetic abnormality rather than the physical characteristics. In the 1960s, chromosome analysis was just starting to be performed on babies with severe developmental problems and multiple malformations in the hopes that it would provide answers about the cause of their problems. Indeed, these and other chromosome abnormalities were found in some of these children. The next step was to define the characteristics of people with each of these “syndromes.”

Hopefully, you have noticed the inconsistency here. The term syndrome should not have been applied here. These conditions were not defined by their physical characteristics but by their underlying genetic change. However, some reverse thinking was applied. Researchers looked for a consistent set of features that would co-occur with each chromosome abnormality. Rather than starting from the physical characteristics (or syndrome) and looking for the genetic change, they started from the genetic change and looked for the physical characteristics. As if each chromosome abnormality was a single entity.

There is another reason that the word “syndrome” is not appropriate to use for chromosome abnormalities. On the molecular level, chromosome abnormalities are very different.

18q- is an excellent illustration of this point. First, we must ask the question, “What is 18q-?” The answer might seem straightforward at first…It is a deletion of a part of chromosome 18q. But what part? You will notice that there is no medical problem, no phenotype associated with this definition. 18q- (and the other chromosome 18 abnormalities) are defined by the genotype. But which genotype? I could easily find 5 people, all with 18q-, with deletions do not overlap with each other. So, at the molecular level they all have unique causes for their condition, but yet they all have 18q-. At some level, people who do not really want to think about it too hard will want to lump them all together for simplicity sake. But for parents who are trying to find other families with children like theirs, who are trying to learn about specific prognoses and treatments, the finer we can define the condition the better. So we better stop using the word syndrome because it implies things to the medical community that are not accurate about our conditions.

So, this leads to our next question...What term should we use instead of the word "syndrome"? That will be the topic of our next post!

Saturday, November 6, 2010

The Easiest Fundraiser Ever!

For many of us Registry-types, the arrival of fall means more than finding a Halloween costume, sending out greeting cards, and throwing the idea of "healthy eating" out the window.

For us, it marks the season of the Registry's annual Phantom Tea!

2010 is the 16th year that we have held this fundraiser, if you can believe it! I think that the thing that makes this fundraiser such a great success is the fact that it is simply so stinkin' easy! It isn't like, say, a gala, where you have to buy a dress or rent a tux or arrange for a taxi and a babysitter, all of which costs a pretty penny. And those pretty pennies don't actually go to helping the organization!

For those who don't know, the beauty of the Phantom Tea is that you don't actually have to DO anything, other than make a donation, in order to attend the event! We do invite you to enjoy a cup of tea on December 5th in honor of the individuals with chromosome 18 conditions and their families. But, if you're too busy or forget or simply don't like tea, we're just as happy with a simple donation!

Are you interested in participating? Head over here to read our invitation and follow the link to the donation page!

Are you interested in inviting others to participate? Even better!! There are a few ways to do that! You can...

1. Send them to the Registry homepage, where they can follow the links to the donation page.
2. Copy and paste the invitation into the body of an email and link to the donation page.
3. Contact the Registry office and request invitations to send to your friends and families
4. Invite your friends via Facebook! We have a page set up, and once you've RSVP'd, you can let your friends know about the event by inviting them to "attend" as well!

As for me, I'm already set for December 5th. I'm looking forward to enjoying a cup of hot raspberry tea...Mmmmm.

The big question I'm having is which teacup to use. You see, I collect teacups. I get one whenever I travel. I'm thinking that, in honor of the Phantom Tea, I'm going to bust out the fancy cups from St. Petersburg, Russia...


Now the main question is which cup! Or maybe I should just drink four cups of tea!

Tuesday, October 19, 2010

Ten Things To Bring to a School Meeting

I've linked to this blog before, but I happen to think that a recent entry on this page deserves some linky goodness as well. It comes to us from stark.raving.mad.mommy, who has several children with special needs.

I've heard a lot of parents talk about the challenges of the school meeting. The blog authoress has provided a few useful tips for a successful school meeting. Enjoy!

Monday, October 18, 2010

In the Name of Love

As I posted a couple of weeks ago, I just recently had my first baby. He was born at 38 weeks, a healthy 7 pounds, 12 ounces. According to his discharge papers, the pregnancy and delivery were “uneventful”. Even as I read that now, I have to giggle a little. Uneventful? Really? Is that what you call 9 months of discomfort, stretch marks, and worry, followed by 24 hours of intense pain, ending with the arrival of a totally helpless little baby who depends on you to meet his every need? To me, that seems pretty eventful.

Even though the pregnancy and delivery were uneventful, we did have one small “event” at his first pediatrician’s appointment. He was diagnosed with jaundice. His bilirubin levels were significantly elevated, but not enough to warrant intervention. At his 8 week appointment, he still looked a little yellow, but his bilirubin levels were only mildly elevated. Nothing to worry about. At least, that’s what the pediatrician says. As his mother, though, I’m holding him up in every different kind of light, staring at the whites of his eyes, asking, “Does he look yellower to you? Is that a sunbeam? Please excuse me while I go set my baby down in it!” My cat is starting to get jealous because the baby is stealing all of his sunbeams!

This has all gotten me thinking…If my experiences with pregnancy and delivery were uneventful, what would an EVENTFUL one be like? If I’m worrying this much over jaundice, a relatively common issue in newborns, what would it be like to have an UNCOMMON issue identified in my son?

Over the course of my ten years in the field of genetic counseling, I’ve taken hundreds of pregnancy and medical histories. So many of the families I’ve met have experienced those “eventful” pregnancies and those “uncommon” medical issues. They were seen in the high risk pregnancy clinics, and their children see specialists and therapists in addition to their pediatrician. Of course, I always knew that these families face unique and difficult challenges. I’m starting to realize, however, that I didn’t fully understand or appreciate the stories that these families share with me. Let me explain.

Parents of children with special needs are forces to be reckoned with. They advocate tirelessly for their children. They fight for better services in the school system. They seek out second (or third or fourth) opinions on how to best care for their child. They become the experts, teaching their child’s providers about their child’s condition. They reach out to other families in similar positions, searching for new ideas and support. Before I was a parent, I wondered at the depths of parental love. The lengths that parents would go to on behalf of their child astonished me. Now that I’m a parent, I understand the words “love” and “devotion” so much better. I cannot think of anything I would not do for this little guy, if/when the need arises. I would step in front of a bus for him without a second thought.

With this deeper understanding, though, comes an even greater awe of the families of children with special needs. In the moment it takes a doctor to utter a diagnosis, reality shifts for those parents. Suddenly, challenges such as sleeping through the night and potty training become secondary to more pressing concerns. “Will my child need surgery? Where can I get an apnea monitor? How can I get more therapy? Will our insurance cover this? Am I making the right decisions for him? Is there anyone else out there dealing with this?” Those dilemmas make routine parenting issues seem minor.

As a new mom, I’m sometimes overwhelmed by my new responsibilities. Feeding, changing, bathing, and soothing the baby alone seems to be a full-time job. And then there’s the household chores, the errands, the part-time job, and the occasional social outing. As I put the baby to bed, I always ask myself the same question, “Where did today go, and why couldn’t I get everything done?”

Parents of special needs children have all of those “typical” things on their plate, but they also have to make and keep all their doctor and therapy appointments, deal with insurance companies, attend IEP meetings, do research on their child’s condition, and more. And some parents go even further, and start raising funds for research, volunteering to organize events, keep blogs, etc. and so forth. Amazing. I’m not sure how they do it, but they do, and I am in awe of them.

So, in summary, having a baby of my own has given me a deeper understanding and appreciation for the parents of children with special needs. They go above and beyond, and all in the name of love.

And, well, because I’m a proud momma, I can’t help posting two pictures of my little boy, who is teaching me new things every single day.

Collaboration with the Trisomy 18 Foundation

Last week, Victoria Miller with the Trisomy 18 Foundation has been visiting the Registry and the Research Center for a couple of days. We have been looking at ways the Registry & the Foundation might work together to increase efficiencies and improve programs. We also had lengthy planning meetings to discuss potential Trisomy 18 research projects that could take advantage of the existing professional staff and expertise available at the Research Center. Stay tuned for future developments!

Monday, October 4, 2010

The Clock Might Be Ticking...

The following was written by the president of the Registry and director of the Chromosome 18 Clinical Research Center, Dr. Jannine Cody:

The Clock Might Be Ticking, but There Is Still Time

I often hear parents of older affected individuals say that they are working hard for the Registry to help those children yet to be born with chromosome 18 abnormalities. They don’t think there will be any research insights or treatments that will help their own children who are young adults. I admit to being the eternal optimist; if I were not, I would not be doing this. That being said, I really would not paint such a fait accompli picture. In the last decade, we have learned that the brain is more similar to the rest of the body than we thought. It was once thought that the brain never added new cells and that brain cells died without being replaced. Now we know that the brain, like the other organs of the body, is undergoing constant remodeling. Since this is such a new finding, we know very little about the factors that influence this remodeling. Still, some interesting things are beginning to emerge that might just give us some hope, where there was none before.

For example, scientists have created a mouse with the same genetic mutation that causes neurofibromatosis (NF). These mice have been found to have problems with attention, problem solving, and visuospatial skills. These are the same sorts of behavioral problems that many people with NF have. Studies have shown which chemical processes are different in this mouse’s brain. This new knowledge and understanding of the altered chemistry provided scientists with ideas about possible treatments. Studies showed that these treatments worked to improve the behavioral problems in adult mice with the NF mutation. However, the treatment did not affect normal mice. This indicates that the treatment is indeed specific for the neurofibromatosis-like defect (Costa et al., 2002; Li et al., 2005).

Similarly, scientists have created a mouse model that has many of the same genetic changes as people with Down syndrome. These adult mice experience behavioral and cognitive improvement when treated with a drug that specifically normalizes the abnormal chemistry in the brain. Again, the same treatment did not improve or change the behavior of the normal mice. This suggests that this treatment is specific to the chemical processes affected by Down syndrome (Fernandez et al., 2007; Rueda et al., 2008)

These are just two examples of genetic conditions that have shown behavioral or cognitive improvement in adult mice following treatment. Other examples are Rubenstein-Taybi syndrome, tuberous sclerosis, Lhermitte-Duclos disease, Cowden syndrome, Fragile X syndrome, Angelman syndrome, and Rett syndrome (Ehninger et al., 2008). These findings have created a radical shift in thinking about the ability of the adult brain to remodel. In turn, this suggests that we can treat adults with developmental disabilities.

We are far from knowing exactly which genes on chromosome 18 cause the majority of developmental disability. We are even further from having targeted treatments. However, have no doubts about it; this is the path we are on. There is still time to make a difference.

References

Costa RM, Federov NB, Kogan JH, Murphy GG, Stern J, Ohno M, Kucherlapati R, Jacks T, Silva AJ. 2002 Mechanism for the learning deficits in a mouse model of neurofibromatosis type 1. Nature 415:526-530.

Ehninger D, Weidong L, Fox K, Stryker MP, Silva AJ. 2008 Reversing Neurodevelopmental Disorders in Adults. Neuron 60:950-960.

Fernandez F, Morishita W, Zuniga E, Nguyen J, Blank M, Malenka RC, Garner CC. 2007 Pharmacotherapy for cognitive impairment in a mouse model of Down syndrome. Nat Neurosci. 10:411-413.

Li W, Cui Y, Kushner SA, Brown RA, Jentsch JD, Frankland PW, Cannon TD, Silva AJ. 2005 The HMG-CoA reductase inhibitor lovastatin reverses the learning and attention deficits in a mouse model of neurofibromatosis type 1. Curr Biol 15:1961-1967.

Ruenda N, Florez J, Martinez-Cue C. 2008 Chronic pentylenetetrazole but not donepezil treatment rescues spatial cognition in Ts65Dn mice, a model for Down syndrome. Neurosci Lett. 433:22-27.

All Quiet on the Chromosome 18 Blog!

Well, it has been quite a long stretch since I last posted on this blog. However, there has been a good reason! The blogstress (myself) had a baby in mid-August! I've been on maternity leave since then. I'm scheduled to get back to business next week, however, and hope to begin posting regularly at that time. Thank you for your patience!!

In the meantime, though, Dr. Jannine Cody had written a guest post that I will post here next!